Anthera Pharmaceuticals, Inc. Share Price
Equities
ANTH
US03674U3005
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -98.51% |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from S&P TMI Index | CI |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from NASDAQ Composite Index | CI |
Sales 2016 | 0.14 11.61 | Sales 2017 | - | Capitalization | 22.85M 1.83B |
---|---|---|---|---|---|
Net income 2016 | -55M -4.4B | Net income 2017 | -26M -2.08B | EV / Sales 2016 | 44,069,434 x |
Net cash position 2016 | 20.84M 1.67B | Net cash position 2017 | 2.2M 176M | EV / Sales 2017 | - |
P/E ratio 2016 |
-0.4
x | P/E ratio 2017 |
-0.58
x | Employees | 21 |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
-98.51% | 26 | |
+2.93% | 108B | |
+8.82% | 105B | |
+3.03% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B |
- Stock Market
- Equities
- ANTH Stock